News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
94,808 Results
Type
Article (7008)
Company Profile (39)
Press Release (87761)
Multimedia
Podcasts (6)
Webinars (1)
Section
Business (27955)
Career Advice (127)
Deals (4030)
Drug Delivery (32)
Drug Development (14439)
Employer Resources (12)
FDA (2941)
Job Trends (2131)
News (49860)
Policy (6075)
Tag
Academia (460)
Accelerated approval (3)
Adcomms (7)
Allergies (33)
Alliances (9095)
ALS (17)
Alzheimer's disease (275)
Antibody-drug conjugate (ADC) (50)
Approvals (2935)
Artificial intelligence (47)
Autoimmune disease (9)
Automation (3)
Bankruptcy (19)
Best Places to Work (1812)
BIOSECURE Act (16)
Biosimilars (78)
Biotechnology (26)
Bladder cancer (25)
Brain cancer (6)
Breast cancer (54)
Cancer (502)
Cardiovascular disease (24)
Career advice (111)
Career pathing (3)
CAR-T (21)
Cell therapy (88)
Cervical cancer (4)
Clinical research (11793)
Collaboration (201)
Compensation (47)
Complete response letters (9)
COVID-19 (559)
CRISPR (6)
C-suite (55)
Cystic fibrosis (14)
Data (490)
Denatured (2)
Depression (7)
Diabetes (39)
Diagnostics (616)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (26)
Drug pricing (25)
Drug shortages (1)
Duchenne muscular dystrophy (31)
Earnings (9625)
Editorial (7)
Employer branding (3)
Employer resources (10)
Events (12097)
Executive appointments (129)
FDA (3315)
Frontotemporal dementia (3)
Funding (155)
Gene editing (26)
Generative AI (6)
Gene therapy (92)
GLP-1 (115)
Government (1329)
Grass and pollen (1)
Guidances (24)
Healthcare (1977)
Huntington's disease (4)
IgA nephropathy (3)
Immunology and inflammation (46)
Indications (10)
Infectious disease (596)
Inflammatory bowel disease (53)
Inflation Reduction Act (4)
Influenza (16)
Intellectual property (12)
Interviews (11)
IPO (1856)
IRA (13)
Job creations (391)
Job search strategy (107)
Kidney cancer (2)
Labor market (2)
Layoffs (58)
Leadership (1)
Legal (564)
Liver cancer (13)
Lung cancer (79)
Lymphoma (31)
Machine learning (1)
Management (2)
Manufacturing (124)
MASH (13)
Medical device (1203)
Medtech (1204)
Mergers & acquisitions (2277)
Metabolic disorders (97)
Multiple sclerosis (19)
NASH (2)
Neurodegenerative disease (19)
Neuropsychiatric disorders (1)
Neuroscience (362)
NextGen: Class of 2025 (702)
Non-profit (360)
Now hiring (11)
Obesity (39)
Opinion (48)
Ovarian cancer (21)
Pain (9)
Pancreatic cancer (14)
Parkinson's disease (11)
Partnered (3)
Patents (33)
Patient recruitment (20)
Peanut (21)
People (8092)
Pharmaceutical (11)
Pharmacy benefit managers (3)
Phase I (3912)
Phase II (4921)
Phase III (4291)
Pipeline (341)
Policy (56)
Postmarket research (303)
Preclinical (1539)
Press Release (66)
Prostate cancer (19)
Psychedelics (5)
Radiopharmaceuticals (43)
Rare diseases (75)
Real estate (927)
Recruiting (4)
Regulatory (4856)
Reports (11)
Research institute (413)
Resumes & cover letters (11)
RNA editing (1)
RSV (11)
Schizophrenia (12)
Series A (35)
Series B (14)
Service/supplier (3)
Sickle cell disease (8)
Special edition (3)
Spinal muscular atrophy (21)
Sponsored (9)
Startups (589)
State (1)
Stomach cancer (3)
Supply chain (11)
Tariffs (12)
The Weekly (4)
Vaccines (194)
Venture capitalists (6)
Weight loss (16)
Women's health (3)
Date
Today (61)
Last 7 days (152)
Last 30 days (564)
Last 365 days (6305)
2025 (2269)
2024 (6577)
2023 (7032)
2022 (9164)
2021 (9575)
2020 (8264)
2019 (5962)
2018 (4603)
2017 (5150)
2016 (4683)
2015 (5341)
2014 (3786)
2013 (2968)
2012 (3038)
2011 (3210)
2010 (2614)
Location
Africa (92)
Alabama (11)
Alaska (1)
Arizona (13)
Arkansas (2)
Asia (7598)
Australia (917)
California (1228)
Canada (253)
China (182)
Colorado (35)
Connecticut (28)
Delaware (48)
Europe (14097)
Florida (150)
Georgia (19)
Idaho (13)
Illinois (54)
India (12)
Indiana (41)
Iowa (2)
Japan (31)
Kansas (5)
Kentucky (9)
Louisiana (2)
Maine (5)
Maryland (327)
Massachusetts (866)
Michigan (26)
Minnesota (50)
Mississippi (1)
Missouri (16)
Montana (5)
Nebraska (1)
Nevada (4)
New Hampshire (3)
New Jersey (481)
New Mexico (5)
New York (353)
North Carolina (207)
North Dakota (8)
Northern California (516)
Ohio (42)
Oklahoma (7)
Oregon (3)
Pennsylvania (202)
Puerto Rico (1)
Rhode Island (5)
South America (138)
South Carolina (2)
Southern California (518)
Tennessee (3)
Texas (165)
United States (4452)
Utah (26)
Virginia (19)
Washington D.C. (6)
Washington State (95)
Wisconsin (9)
94,808 Results for "nucleus biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Red Nucleus Announces Acquisition of Coeus
February 4, 2025
·
3 min read
Press Releases
Nucleus Genomics Hires Romain Daguet, Award-Winning Founder and Engineer
February 26, 2025
·
2 min read
Manufacturing
Radiopharma-Focused CDMO Nucleus Unveils Two New Plants, Looks to Create 100 Jobs
Nucleus RadioPharma’s two sites are meant to help address the industry’s lack of manufacturing and development capabilities, as well as geographic limitations associated with the short half-life of many radioactive components.
October 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Nucleus Biologics Launches NB-KUL™ DF: A DMSO-Free, Chemically-Defined Cryomedia Revolutionizing Cell and Gene Therapy Cryopreservation
October 15, 2024
·
3 min read
BioMidwest
Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment
Nucleus RadioPharma today announced the closing of a Series A extension round with new investor AstraZeneca (LSE/STO/Nasdaq: AZN).
June 5, 2024
·
4 min read
Business
Core Biogenesis and Nucleus Biologics Announce Strategic Collaboration for Manufacturing and Distribution of Cost-Effective and Sustainable Recombinant Proteins
n a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, has signed a manufacturing, distribution, and collaboration agreement with Core Biogenesis, an innovator in the field of recombinant human proteins expressed in plants.
January 10, 2024
·
4 min read
Pharm Country
Nucleus Genomics launches to bring whole-genome sequencing to the public
Nucleus Genomics announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.
March 25, 2024
·
3 min read
BioMidwest
ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
ARTBIO, Inc. and Nucleus RadioPharma Inc. announced a strategic manufacturing and supply agreement to support ARTBIO’s therapeutic product manufacturing.
May 7, 2024
·
3 min read
BioMidwest
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177
Eckert & Ziegler and Nucleus RadioPharma signed extensive supply agreements for major therapeutic radioisotopes.
January 31, 2024
·
3 min read
Press Releases
Bora Biologics Unveils Cutting-Edge Innovations at Festival of Biologics 2025
April 17, 2025
·
2 min read
1 of 9,481
Next
